NCT00273676View on ClinicalTrials.gov

Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia

PHASE4CompletedINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

July 31, 2000

Study Completion Date

March 31, 2004

Conditions

Severe Communtity-Acquired Pneumonia

Interventions

PROCEDURE

Conversion to oral antibiotic treatment after 3 days of intravenous antibiotic treatment

Trial Locations (1)

3508 GA

University Medical Center, Utrecht

All Listed Sponsors

collaborator

Dutch Health Care Insurance Board

OTHER

lead

UMC Utrecht

OTHER

NCT00273676 - Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia | Biotech Hunter | Biotech Hunter